Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
5721 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
Proteasome activator subunit 2 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
PSME2 |
SynonymsGene synonyms aliases
|
PA28B, PA28beta, REGbeta |
ChromosomeChromosome number
|
14 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
14q12 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
The 26S proteasome is a multicatalytic proteinase complex with a highly ordered structure composed of 2 complexes, a 20S core and a 19S regulator. The 20S core is composed of 4 rings of 28 non-identical subunits; 2 rings are composed of 7 alpha subunits and 2 rings are composed of 7 beta subunits. The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase subunits, and a lid, which contains up to 10 non-ATPase subunits. Proteasomes are distributed throughout eukaryotic cells at a high concentration and cleave peptides in an ATP/ubiquitin-dependent process in a non-lysosomal pathway. An essential function of a modified proteasome, the immunoproteasome, is the processing of class I MHC peptides. The immunoproteasome contains an alternate regulator, referred to as the 11S regulator or PA28, that replaces the 19S regulator. Three subunits (alpha, beta and gamma) of the 11S regulator have been identified. This gene encodes the beta subunit of the 11S regulator, one of the two 11S subunits that is induced by gamma-interferon. Three beta and three alpha subunits combine to form a heterohexameric ring. Six pseudogenes have been identified on chromosomes 4, 5, 8, 10 and 13. [provided by RefSeq, Jul 2008] |
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0000165 |
Process |
MAPK cascade |
TAS |
|
GO:0000209 |
Process |
Protein polyubiquitination |
TAS |
|
GO:0000502 |
Component |
Proteasome complex |
TAS |
8811196 |
GO:0002223 |
Process |
Stimulatory C-type lectin receptor signaling pathway |
TAS |
|
GO:0002479 |
Process |
Antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
TAS |
|
GO:0005515 |
Function |
Protein binding |
IPI |
16189514, 32296183 |
GO:0005654 |
Component |
Nucleoplasm |
IBA |
21873635 |
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0005737 |
Component |
Cytoplasm |
IBA |
21873635 |
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0006521 |
Process |
Regulation of cellular amino acid metabolic process |
TAS |
|
GO:0008537 |
Component |
Proteasome activator complex |
IEA |
|
GO:0010950 |
Process |
Positive regulation of endopeptidase activity |
IBA |
21873635 |
GO:0010972 |
Process |
Negative regulation of G2/M transition of mitotic cell cycle |
TAS |
|
GO:0016020 |
Component |
Membrane |
HDA |
19946888 |
GO:0016579 |
Process |
Protein deubiquitination |
TAS |
|
GO:0031145 |
Process |
Anaphase-promoting complex-dependent catabolic process |
TAS |
|
GO:0031146 |
Process |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
TAS |
|
GO:0033209 |
Process |
Tumor necrosis factor-mediated signaling pathway |
TAS |
|
GO:0035722 |
Process |
Interleukin-12-mediated signaling pathway |
TAS |
|
GO:0038061 |
Process |
NIK/NF-kappaB signaling |
TAS |
|
GO:0038095 |
Process |
Fc-epsilon receptor signaling pathway |
TAS |
|
GO:0042802 |
Function |
Identical protein binding |
IPI |
16189514, 32296183 |
GO:0043161 |
Process |
Proteasome-mediated ubiquitin-dependent protein catabolic process |
TAS |
|
GO:0043488 |
Process |
Regulation of mRNA stability |
TAS |
|
GO:0043687 |
Process |
Post-translational protein modification |
TAS |
|
GO:0050852 |
Process |
T cell receptor signaling pathway |
TAS |
|
GO:0055085 |
Process |
Transmembrane transport |
TAS |
|
GO:0060071 |
Process |
Wnt signaling pathway, planar cell polarity pathway |
TAS |
|
GO:0061133 |
Function |
Endopeptidase activator activity |
IBA |
21873635 |
GO:0061136 |
Process |
Regulation of proteasomal protein catabolic process |
IBA |
21873635 |
GO:0061418 |
Process |
Regulation of transcription from RNA polymerase II promoter in response to hypoxia |
TAS |
|
GO:0070062 |
Component |
Extracellular exosome |
HDA |
19056867, 23533145 |
GO:0070498 |
Process |
Interleukin-1-mediated signaling pathway |
TAS |
|
GO:0090090 |
Process |
Negative regulation of canonical Wnt signaling pathway |
TAS |
|
GO:0090263 |
Process |
Positive regulation of canonical Wnt signaling pathway |
TAS |
|
GO:1901990 |
Process |
Regulation of mitotic cell cycle phase transition |
TAS |
|
GO:1902036 |
Process |
Regulation of hematopoietic stem cell differentiation |
TAS |
|
GO:2000045 |
Process |
Regulation of G1/S transition of mitotic cell cycle |
IBA |
21873635 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
Q9UL46 |
Protein name |
Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta) |
Protein function |
Implicated in immunoproteasome assembly and required for efficient antigen processing. The PA28 activator complex enhances the generation of class I binding peptides by altering the cleavage pattern of the proteasome. |
PDB |
7DR6
,
7DRW
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF02251 |
PA28_alpha |
11 → 71 |
Proteasome activator pa28 alpha subunit |
Family |
PF02252 |
PA28_beta |
93 → 237 |
Proteasome activator pa28 beta subunit |
Family |
|
Sequence |
|
Sequence length |
239 |
Interactions |
View interactions |